The respiratory devices and equipment (therapeutic) market size has grown strongly in recent years. It will grow from $23.68 billion in 2025 to $25.59 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to increasing prevalence of chronic respiratory diseases, rising hospital admissions for respiratory disorders, expansion of homecare medical equipment usage, availability of advanced ventilator technologies, growth in aging population.
The respiratory devices and equipment (therapeutic) market size is expected to see strong growth in the next few years. It will grow to $35.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring solutions, rising adoption of home-based respiratory care, growing investments in smart medical devices, expansion of telehealth-supported respiratory therapies, increasing focus on early disease management. Major trends in the forecast period include increasing adoption of connected respiratory devices, rising demand for portable and homecare respiratory equipment, growing integration of smart monitoring features, expansion of non-invasive ventilation technologies, enhanced focus on patient-centric device design.
The growing number of smokers is expected to drive the expansion of the respiratory devices and equipment (therapeutic) market in the coming years. Smokers are individuals who consume tobacco products such as cigarettes, cigars, or pipes. Therapeutic respiratory devices and equipment, including inhalers and nebulizers, are used by smokers to help manage respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, and lung cancer. For example, in March 2024, according to Statistics Canada, the total number of cigarettes sold in Canada reached 1.1 billion, representing a 24% decline compared with March 2023. Therefore, the increasing number of smokers is contributing to the growth of the respiratory devices and equipment (therapeutic) market.
Major companies operating in the respiratory devices and equipment (therapeutic) market are concentrating on product innovation, such as the VitaloPFT series, to deliver reliable solutions to customers. The VitaloPFT series is used as respiratory devices and equipment (therapeutic) to efficiently and effectively diagnose, monitor, and manage patients’ respiratory health. For example, in March 2023, Vitalograph Ltd., a UK-based manufacturer of respiratory medical devices, launched the VitaloPFT series. The VitaloPFT series is designed to provide advanced respiratory diagnostic solutions to hospitals and other secondary care facilities that require complex pulmonary function testing. The series includes the VitaloROV+, a portable pulmonary function testing (PFT) device that enables accurate point-of-care testing for patients.
In April 2024, Clario, a US-based healthcare company, acquired ArtiQ for an undisclosed amount. Through this acquisition, Clario enhanced its Respiratory Solutions portfolio by integrating scalable AI technology to improve data quality, streamline clinical trials, and expand its global reach, enabling broader applications beyond respiratory care. ArtiQ is a Belgium-based healthcare company focused on improving diagnostic and monitoring equipment for respiratory conditions.
Major companies operating in the respiratory devices and equipment (therapeutic) market are Hamilton Medical AG, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Philips Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Drägerwerk AG & Co. KGaA, Medtronic plc, Masimo Corporation, CareFusion Corporation, Getinge AB, Hill-Rom Holdings Inc., Becton Dickinson and Company, Air Liquide S.A., Vyaire Medical Inc., Compumedics Limited, Covidien plc, Mindray Medical International Limited, Inogen Inc., Nihon Kohden Corporation, Siemens Healthcare GmbH, Teleflex Incorporated, Breas Medical AB, AirSep Corporation, Rotech Healthcare Inc., 3B Medical Inc.
Asia-Pacific was the largest region in the respiratory devices and equipment (therapeutic) market in 2025. Western Europe was the second-largest region in the respiratory devices and equipment (therapeutic) market. The regions covered in the respiratory devices and equipment (therapeutic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory devices and equipment (therapeutic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory devices and equipment (therapeutic) market by increasing costs of imported sensors, compressors, electronic control units, filters, and precision components used in ventilators, oxygen concentrators, and positive airway pressure devices. Hospitals and homecare providers in North America and Europe are most affected due to reliance on imported medical-grade components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising procurement costs and extending replacement cycles for healthcare facilities. However, they are also encouraging domestic manufacturing, regional supplier development, and increased investment in locally assembled respiratory care equipment.
The respiratory devices and equipment (therapeutic) market research report is one of a series of new reports that provides respiratory devices and equipment (therapeutic) market statistics, including respiratory devices and equipment (therapeutic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic) market share, detailed respiratory devices and equipment (therapeutic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic) industry. This respiratory devices and equipment (therapeutic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory devices and equipment in the therapeutic category are essential for treating patients with acute or chronic respiratory disorders, including conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, and sleep disorders.
The primary products within the respiratory devices and equipment (therapeutic) market encompass nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, capnographs, and gas analyzers. Nebulizers, for instance, are small devices that convert liquid medicine into a mist, which is then inhaled by patients through a connected mouthpiece. Various technologies are employed in these respiratory devices and equipment, including HEPA filters, electrostatic filtration, microsphere separation, hollow fiber filtration, and other filtration methods. The market for these therapeutic devices is segmented based on end-users, with applications in both home care settings and hospitals.
The respiratory devices and equipment (therapeutic) market consist of sales of instruments such as nebulizers, oxygen concentrators, positive airway pressure devices, ventilators, inhalers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The respiratory devices and equipment (therapeutic) market size is expected to see strong growth in the next few years. It will grow to $35.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring solutions, rising adoption of home-based respiratory care, growing investments in smart medical devices, expansion of telehealth-supported respiratory therapies, increasing focus on early disease management. Major trends in the forecast period include increasing adoption of connected respiratory devices, rising demand for portable and homecare respiratory equipment, growing integration of smart monitoring features, expansion of non-invasive ventilation technologies, enhanced focus on patient-centric device design.
The growing number of smokers is expected to drive the expansion of the respiratory devices and equipment (therapeutic) market in the coming years. Smokers are individuals who consume tobacco products such as cigarettes, cigars, or pipes. Therapeutic respiratory devices and equipment, including inhalers and nebulizers, are used by smokers to help manage respiratory conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, and lung cancer. For example, in March 2024, according to Statistics Canada, the total number of cigarettes sold in Canada reached 1.1 billion, representing a 24% decline compared with March 2023. Therefore, the increasing number of smokers is contributing to the growth of the respiratory devices and equipment (therapeutic) market.
Major companies operating in the respiratory devices and equipment (therapeutic) market are concentrating on product innovation, such as the VitaloPFT series, to deliver reliable solutions to customers. The VitaloPFT series is used as respiratory devices and equipment (therapeutic) to efficiently and effectively diagnose, monitor, and manage patients’ respiratory health. For example, in March 2023, Vitalograph Ltd., a UK-based manufacturer of respiratory medical devices, launched the VitaloPFT series. The VitaloPFT series is designed to provide advanced respiratory diagnostic solutions to hospitals and other secondary care facilities that require complex pulmonary function testing. The series includes the VitaloROV+, a portable pulmonary function testing (PFT) device that enables accurate point-of-care testing for patients.
In April 2024, Clario, a US-based healthcare company, acquired ArtiQ for an undisclosed amount. Through this acquisition, Clario enhanced its Respiratory Solutions portfolio by integrating scalable AI technology to improve data quality, streamline clinical trials, and expand its global reach, enabling broader applications beyond respiratory care. ArtiQ is a Belgium-based healthcare company focused on improving diagnostic and monitoring equipment for respiratory conditions.
Major companies operating in the respiratory devices and equipment (therapeutic) market are Hamilton Medical AG, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Philips Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Drägerwerk AG & Co. KGaA, Medtronic plc, Masimo Corporation, CareFusion Corporation, Getinge AB, Hill-Rom Holdings Inc., Becton Dickinson and Company, Air Liquide S.A., Vyaire Medical Inc., Compumedics Limited, Covidien plc, Mindray Medical International Limited, Inogen Inc., Nihon Kohden Corporation, Siemens Healthcare GmbH, Teleflex Incorporated, Breas Medical AB, AirSep Corporation, Rotech Healthcare Inc., 3B Medical Inc.
Asia-Pacific was the largest region in the respiratory devices and equipment (therapeutic) market in 2025. Western Europe was the second-largest region in the respiratory devices and equipment (therapeutic) market. The regions covered in the respiratory devices and equipment (therapeutic) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory devices and equipment (therapeutic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory devices and equipment (therapeutic) market by increasing costs of imported sensors, compressors, electronic control units, filters, and precision components used in ventilators, oxygen concentrators, and positive airway pressure devices. Hospitals and homecare providers in North America and Europe are most affected due to reliance on imported medical-grade components, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising procurement costs and extending replacement cycles for healthcare facilities. However, they are also encouraging domestic manufacturing, regional supplier development, and increased investment in locally assembled respiratory care equipment.
The respiratory devices and equipment (therapeutic) market research report is one of a series of new reports that provides respiratory devices and equipment (therapeutic) market statistics, including respiratory devices and equipment (therapeutic) industry global market size, regional shares, competitors with a respiratory devices and equipment (therapeutic) market share, detailed respiratory devices and equipment (therapeutic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (therapeutic) industry. This respiratory devices and equipment (therapeutic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory devices and equipment in the therapeutic category are essential for treating patients with acute or chronic respiratory disorders, including conditions such as chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, and sleep disorders.
The primary products within the respiratory devices and equipment (therapeutic) market encompass nebulizers, humidifiers, oxygen concentrators, positive airway pressure devices, ventilators, capnographs, and gas analyzers. Nebulizers, for instance, are small devices that convert liquid medicine into a mist, which is then inhaled by patients through a connected mouthpiece. Various technologies are employed in these respiratory devices and equipment, including HEPA filters, electrostatic filtration, microsphere separation, hollow fiber filtration, and other filtration methods. The market for these therapeutic devices is segmented based on end-users, with applications in both home care settings and hospitals.
The respiratory devices and equipment (therapeutic) market consist of sales of instruments such as nebulizers, oxygen concentrators, positive airway pressure devices, ventilators, inhalers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Respiratory Devices and Equipment (Therapeutic) Market Characteristics
3. Respiratory Devices and Equipment (Therapeutic) Market Supply Chain Analysis
4. Global Respiratory Devices and Equipment (Therapeutic) Market Trends and Strategies
5. Respiratory Devices and Equipment (Therapeutic) Market Analysis of End Use Industries
7. Global Respiratory Devices and Equipment (Therapeutic) Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Respiratory Devices and Equipment (Therapeutic) Total Addressable Market (TAM) Analysis for the Market
9. Respiratory Devices and Equipment (Therapeutic) Market Segmentation
10. Respiratory Devices and Equipment (Therapeutic) Market Regional and Country Analysis
11. Asia-Pacific Respiratory Devices and Equipment (Therapeutic) Market
12. China Respiratory Devices and Equipment (Therapeutic) Market
13. India Respiratory Devices and Equipment (Therapeutic) Market
14. Japan Respiratory Devices and Equipment (Therapeutic) Market
15. Australia Respiratory Devices and Equipment (Therapeutic) Market
16. Indonesia Respiratory Devices and Equipment (Therapeutic) Market
17. South Korea Respiratory Devices and Equipment (Therapeutic) Market
18. Taiwan Respiratory Devices and Equipment (Therapeutic) Market
19. South East Asia Respiratory Devices and Equipment (Therapeutic) Market
20. Western Europe Respiratory Devices and Equipment (Therapeutic) Market
21. UK Respiratory Devices and Equipment (Therapeutic) Market
22. Germany Respiratory Devices and Equipment (Therapeutic) Market
23. France Respiratory Devices and Equipment (Therapeutic) Market
24. Italy Respiratory Devices and Equipment (Therapeutic) Market
25. Spain Respiratory Devices and Equipment (Therapeutic) Market
26. Eastern Europe Respiratory Devices and Equipment (Therapeutic) Market
27. Russia Respiratory Devices and Equipment (Therapeutic) Market
28. North America Respiratory Devices and Equipment (Therapeutic) Market
29. USA Respiratory Devices and Equipment (Therapeutic) Market
30. Canada Respiratory Devices and Equipment (Therapeutic) Market
31. South America Respiratory Devices and Equipment (Therapeutic) Market
32. Brazil Respiratory Devices and Equipment (Therapeutic) Market
33. Middle East Respiratory Devices and Equipment (Therapeutic) Market
34. Africa Respiratory Devices and Equipment (Therapeutic) Market
36. Respiratory Devices and Equipment (Therapeutic) Market Competitive Landscape and Company Profiles
37. Respiratory Devices and Equipment (Therapeutic) Market Other Major and Innovative Companies
40. Respiratory Devices and Equipment (Therapeutic) Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Respiratory Devices And Equipment (Therapeutic) Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses respiratory devices and equipment (therapeutic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for respiratory devices and equipment (therapeutic)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory devices and equipment (therapeutic) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Nebulizers; Humidifiers; Oxygen Concentrators; Positive Airway Pressure Devices; Ventilators; Capnographs; Gas Analyzers2) By Technology: HEPA Filter; Electrostatic Filtration; Microsphere Separation; Hollow Fiber Filtration; Other Technologies
3) By End-User: Homecare settings; Hospitals
Subsegments:
1) By Nebulizers: Pneumatic Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers2) By Humidifiers: Bubble Humidifiers; Passover Humidifiers; Evaporative Humidifiers; Hot-Wire Humidifiers
3) By Oxygen Concentrators: Portable Oxygen Concentrators; Stationary Oxygen Concentrators
4) By Positive Airway Pressure Devices: Continuous Positive Airway Pressure (CPAP); Auto-Adjusting Positive Airway Pressure (APAP); Bi-Level Positive Airway Pressure (BiPAP)
5) By Ventilators: Non-invasive Ventilators; Invasive Ventilators; Transport Ventilators; ICU Ventilators
6) By Capnographs: Mainstream Capnographs; Sidestream Capnographs
7) By Gas Analyzers: Oxygen Analyzers; Carbon Dioxide Analyzers; Nitrous Oxide Analyzers; Multi-Gas Analyzers
Companies Mentioned: Hamilton Medical AG; Koninklijke Philips N.V.; Smiths Medical; GE Healthcare; Philips Healthcare; Chart Industries Inc.; Invacare Corporation; Fisher & Paykel Healthcare Limited; ResMed Inc.; Drägerwerk AG & Co. KGaA; Medtronic plc; Masimo Corporation; CareFusion Corporation; Getinge AB; Hill-Rom Holdings Inc.; Becton Dickinson and Company; Air Liquide S.A.; Vyaire Medical Inc.; Compumedics Limited; Covidien plc; Mindray Medical International Limited; Inogen Inc.; Nihon Kohden Corporation; Siemens Healthcare GmbH; Teleflex Incorporated; Breas Medical AB; AirSep Corporation; Rotech Healthcare Inc.; 3B Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Respiratory Devices and Equipment (Therapeutic) market report include:- Hamilton Medical AG
- Koninklijke Philips N.V.
- Smiths Medical
- GE Healthcare
- Philips Healthcare
- Chart Industries Inc.
- Invacare Corporation
- Fisher & Paykel Healthcare Limited
- ResMed Inc.
- Drägerwerk AG & Co. KGaA
- Medtronic plc
- Masimo Corporation
- CareFusion Corporation
- Getinge AB
- Hill-Rom Holdings Inc.
- Becton Dickinson and Company
- Air Liquide S.A.
- Vyaire Medical Inc.
- Compumedics Limited
- Covidien plc
- Mindray Medical International Limited
- Inogen Inc.
- Nihon Kohden Corporation
- Siemens Healthcare GmbH
- Teleflex Incorporated
- Breas Medical AB
- AirSep Corporation
- Rotech Healthcare Inc.
- 3B Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 25.59 Billion |
| Forecasted Market Value ( USD | $ 35.19 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
